Sphingosine Kinase 1 (human recombinant)

Product Description

Stability : 6 months
Formulation :
10 µg in 25 mM Tris-HCl, pH 8.0, containing 100 mM sodium chloride, 0.05% Tween 20, 50% glycerol, and 3 mM DTT
Description :
Sphingosine kinase (SPHK) is an important enzyme in the sphingolipid metabolic pathway. SPHKs phosphorylate D-erythro-sphingosine to yield sphingosine-1-phosphate (S1P). To date, two isoforms of SPHK, SPHK 1 and SPHK 2, have been identified and characterized from mammalian cells. Among them, SPHK 1 has been implicated to play a role in signalling pathways in mast cells and in TNF-α-triggered responses of fibroblasts and epithelial cells. Recent findings also indicate that SPHK 1 mRNA levels are increased in a variety of human tumors. Brain tumors with high SPHK 1 expression correlated with poor survival of patients and high expression of SPHK 1 appears to be an oncogenic event required for erythroleukaemia progression. Thus SPHK is a potential therapeutic target for the control of cancer and inflammation. 
Purity : >80% by SDS-PAGE
Storage : -80°C

Disclaimer: the information on this website is from the internet for reference only. Please refer to the actual instructions attached to the product and the final interpretation is owned by the company.

Send inquiry online For more product information and prices

(Pharmaceutical Ingredients Manufacturer & Supplier & Exporter.)

After sending the online inquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email. —— Green Stone Swiss

Email: sales@raw-pharmaceutical-materials.com
Tel: +86 592 5365887
WhatsApp: +86 189 6515 7632
Send inquiry online: